Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for endothelial dysfunction in severe sepsis
ACTRN12607000393459Phase 2Not yet recruiting
- Sponsor
- Dr Josh Davis
- Start
- Aug 2007
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in sepsis comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Change in endothelial function. Planned start Aug 2007; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
sepsis
Beyond the preview
Go deeper on ACTRN12607000393459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000393459.